# Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.

> **NCT06044974** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 29 (actual)

## Conditions studied

- Temporomandibular Joint Disorders

## Interventions

- **DEVICE:** Nd-YAG Fotona
- **DRUG:** Epidermal Growth Factor

## Key facts

- **NCT ID:** NCT06044974
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-21
- **Primary completion:** 2023-08-10
- **Final completion:** 2024-01-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06044974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06044974, "Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06044974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*